The Label Division of CCL Industries Inc., Toronto, has acquired the shares of Lucas-Insertco, which manufactures consumer instructional leaflets, commonly known as “inserts” and “outserts”, for the pharmaceutical industry. The price was about Cdn$18 million, including debt assumed.
Lucas-Insertco operates from two leased facilities in Baltimore and San German, Puerto Rico, and has 185 employees.
“Inserts and outserts, alongside our core products, represent critical control items in the pharmaceutical packaging process and are therefore subject to the same quality, GMP and FDA standards,” says Donald G. Lang, president and CEO of CCL Industries. “Consequently, many major North American pharmaceutical companies see strategic advantage to acquiring these products from a single source.”
Geoffrey T. Martin, president of CCL Label, says, “We have had an alliance arrangement with Lucas-Insertco for some time to jointly sell our respective products to the healthcare industry. Both companies felt this next step was necessary to expand our capacity and capability to supply inserts and outserts in a more strategic and significant way to our global healthcare customers.”
CCL Industries manufactures a variety of packaging products, including specialty aluminum and plastics packaging, and product labeling, to major consumer brands companies. It employs 7,000 people and operates 35 production plants in North America, Central America, and Europe.